Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Where Will Tesla Stock Be In 2030? Analyst Weighs In

Tesla, Inc. (NASDAQ: TSLA) shares barely budged despite all the hype surrounding the Cyber Rodeo event held this week.

Benzinga

Tesla CEO Elon Musk Is Now $100B Richer Than Jeff Bezos: Here's How Much He's Worth

According to the latest Forbes billionaires list, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk increased his net worth to $282 billion, and is now over $100 billion richer than Amazon.com, Inc (NASDAQ: AMZN)

Benzinga

EV Week In Review: Musk Stars At 'Cyber Rodeo' Show, GM Dips Heel Into Low-cost EVs, Toyota Takes A Leaf Out of Tesla's Book And More

EV stocks fell across the board this week as they towed in line with the broader market, with some company-specific news and geopolitical tensions also serving to exacerbate sentiment. Tesla, Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Here's Why Nio Is Suspending Production And Asking For 'Understanding From Customers'

China is grappling with a renewed surge of COVID-19 and the impact is reverberating across the corporate landscape. Local EV startup Nio, Inc. (NASDAQ: NIO) has joined EV leader Tesla, Inc.

Benzinga

Why Dave Portnoy Loves Elon Musk Taking A Stake In Twitter

News that Tesla Inc (NASDAQ: TSLA) CEO Elon Musk took a large stake in Twitter Inc (NYSE:

Benzinga

5 Things On Dogecoin Community's Radar With Elon Musk Joining Twitter Board

The Dogecoin (CRYPTO: DOGE) community has taken stock of Tesla Inc (NASDAQ: TSLA) CEO Elon Musk picking up over a 9% stake in Twitter Inc&nbs

Benzinga

Dave Portnoy Is Rooting Against Tiger Woods At 2022 Masters Tournament

The founder of a leading sports media company is rooting against legendary golfer Tiger Woods at the 2022 Masters Tournament.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Here's How Much $100 Invested In Atlassian Corporation 5 Years Ago Would Be Worth Today

Atlassian Corporation (NASDAQ:TEAM) has outperformed the market over the past 5 years by 40.44% on an annualized basis producing an average annual return of 54.18%. Currently, Atlassian Corporation has a market capitalization of $68.95 billion.

Benzinga

What To Expect From Q1 2022 Earnings Season

The second earnings season of the year is due to start next week once the US banks report how they performed in the first three months of 2022. Earnings Surprises Dominated The Last Earnings Season

Benzinga

Looking Into Teradyne Inc's Recent Short Interest

Teradyne Inc's (NASDAQ:TER) short percent of float has fallen 5.04% since its last report. The company recently reported that it has 5.49 million shares sold short, which is 3.39% of all regular shares that are available for trading.

Benzinga

Could Netflix Be Targeting Live NFL Streaming And Docuseries? Should Apple, Amazon And ESPN Be Worried?

Streaming giant Netflix Inc (NASDAQ: NFLX) is well-known for its partnered content and original programming. Could live sports and a continued focus on sports docuseries be a huge growth driver for the company going forward?

Benzinga

FTC Solar, Shoals Technologies Slide After Piper Sandler Downgrade

Piper Sandler analyst Kashy Harrison downgraded two electrical equipment companies, citing the U.S. Department of Commerce's decision to investigate antidumping and countervailing duty circumvention in certain Southeast Asian countries that will cause project delays.

Benzinga

9 Best Stocks To Buy In Q2? AMD, Lululemon And More

The year got off to a bumpy start for investors, and the S&P 500 is now down 5.6% year-to-date in 2022.

Benzinga

Why C4 Therapeutics Stock Is Plunging Today

C4 Therapeutics Inc (NASDAQ: CCCC) shares are trading significantly lower Friday afternoon after the company presented data from Cohort A of its ongoing Phase 1/2 clinical trial of CFT7455.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Needham Sees Clear View Into STAAR Surgical's Durable Double-Digit Revenue Expansion

Needham is initiating coverage on STAAR Surgical Company (NASDAQ:STAA) with a Buy rating and an $87 price target. The analysts note that FDA approval of STAA's EVO Implantable Collamer Lens (ICLs) should serve as a meaningful tailwind for revenue. The Company generates most of its revenue from outside US markets. But after the FDA approval…

Benzinga

Clovis Oncology Targeted Cancer Radiation Therapy Shows Greater Tumor Inhibition

Clovis Oncology Inc (NASDAQ: CLVS) announced two abstracts featuring

Benzinga

Christian Angermayer Buys 1 Million Shares Of Atai Life, His Own Company

Christian Angermayer, founder and chairman of Atai Life Sciences (NASDAQ:ATAI), told Twitter that he bought 1 million shares of his company. “Many #biotech stocks are cheap at the moment. In my opinion, Atai Life Sciences AG stands out though for two reasons: the size of the market (unfortunately) the fact…

Benzinga

If You Invested $1000 In Dollar Tree 5 Years Ago, Here's How Much You Would Have Today

Dollar Tree (NASDAQ:DLTR) has outperformed the market over the past 5 years by 2.38% on an annualized basis producing an average annual return of 16.21%. Currently, Dollar Tree has a market capitalization of $36.78 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2%

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Benzinga

Why Robinhood Markets Stock Is Falling Today

Robinhood Markets Inc (NASDAQ: HOOD) shares are trading lower Friday following a downgrade from Goldman Sachs. Goldman Sachs analyst Will Nance downgraded Robinhood from a Neutral rating to a Sell rating and announced a $13 price target.

Benzinga

Genocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor Patients

Genocea Biosciences Inc (NASDAQ: GNCA) has

Benzinga

Read Why Needham Is Bullish On This Pet Retailer

Needham analyst Anna Andreeva gave Petco Health And Wellness Co Inc (NASDAQ:WOOF) a Buy rating with a price target of $30.00 (45% upside). Andreeva notes Petco is becoming an omni-channel powerhouse after revamping its digital capabilities under CEO Ron Coughlin. The analyst thinks that the company’s bundled offerings model has a significant advantage over digital-only players. Petco…

Benzinga

Aterian Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Aterian. Looking at options history for Aterian (NASDAQ:ATER) we detected 14 strange trades.

Benzinga

This Is What Whales Are Betting On American Airlines Group

A whale with a lot of money to spend has taken a noticeably bearish stance on American Airlines Group. Looking at options history for American Airlines Group (NASDAQ:AAL) we detected 10 strange trades.

Benzinga

12 Information Technology Stocks Moving In Friday's Intraday Session

1 … 769 770 771 772

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.